Pulmonary metastases arise when a primary malignancy spreads to the lungs. Treatment planning is shaped by the nature of the originating tumor and how it responds to systemic therapies, making individualised protocol selection essential.
Management of pulmonary metastases is determined by the primary tumor type and its specific sensitivity to antineoplastic treatments. Because different primary malignancies carry distinct biological profiles, the appropriate systemic approach — and expected outcomes — vary considerably from case to case.
DOI: 10.21037/asj-21-81
The management of metastatic tumors with pulmonary metastases is usually determined by the primary tumor and typically involves systemic treatments with palliative intent, with varying regimens and results based on the sensitivity to antineoplastic treatments of the involved malignancy.
View source ↗